Cancer Diagnostics: Decision Criteria for Marker Utilization in the Clinic

Author： Taube Sheila E.   Jacobson James W.   Lively Tracy G.  

Publisher： Adis International

ISSN： 1175-2203

Source： American Journal of PharmacoGenomics, Vol.5, Iss.6, 2005-01, pp. : 357-364

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epigenomics Poised to Enter Cancer Diagnostics Market with DNA Methylation Marker Technology

By  

Pharmaceutical & Diagnostic Innovation, Vol. 2, Iss. 5, 2004-10 ,pp. : 51-55

Adis International

Access to resources Recommend Favorite

A Cancer-Related Fatigue Clinic: Opportunities and Challenges

By Escalante Carmen P.   Manzullo Ellen   Valdres Rosalie  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 1, Iss. 3, 2003-07 ,pp. : 333-343

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Filling the Void in Cancer Diagnostics: Immunicon Has the Technology

By  

Pharmaceutical Innovation, Vol. 12, Iss. 4, 2003-06 ,pp. : 48-52

Adis International

Access to resources Recommend Favorite

Emotion, Decision-Making and Substance Dependence: A Somatic-Marker Model of Addiction

By  

Current Neuropharmacology, Vol. 4, Iss. 1, 2006-01 ,pp. : 17-31

Bentham Science Publishers

Access to resources Recommend Favorite

14-3-3ζ as a prognostic marker and therapeutic target for cancer

By Neal Christopher L   Yu Dihua  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 12, 2010-12 ,pp. : 1343-1354

Informa Healthcare

Access to resources Recommend Favorite